These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Di Rosa M; Dell'Ombra N; Zambito AM; Malaguarnera M; Nicoletti F; Malaguarnera L Eur J Neurosci; 2006 May; 23(10):2648-56. PubMed ID: 16817867 [TBL] [Abstract][Full Text] [Related]
7. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827 [TBL] [Abstract][Full Text] [Related]
8. High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. Rahman SM; Van Dam AM; Schultzberg M; Crisby M J Neuroimmunol; 2005 Dec; 169(1-2):59-67. PubMed ID: 16198427 [TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049 [TBL] [Abstract][Full Text] [Related]
10. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease. Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248 [TBL] [Abstract][Full Text] [Related]
11. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease. Hampel H; Shen Y Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117 [TBL] [Abstract][Full Text] [Related]
12. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538 [TBL] [Abstract][Full Text] [Related]
13. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597 [TBL] [Abstract][Full Text] [Related]
14. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA; Nafe R; Schlote W Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758 [TBL] [Abstract][Full Text] [Related]
16. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966 [TBL] [Abstract][Full Text] [Related]
17. Transcription factor Sp1 dysregulation in Alzheimer's disease. Citron BA; Dennis JS; Zeitlin RS; Echeverria V J Neurosci Res; 2008 Aug; 86(11):2499-504. PubMed ID: 18449948 [TBL] [Abstract][Full Text] [Related]
18. Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease. Culpan D; Prince JA; Matthews S; Palmer L; Hughes A; Love S; Kehoe PG; Wilcock GK Neurosci Lett; 2006 Nov; 408(2):141-5. PubMed ID: 16973274 [TBL] [Abstract][Full Text] [Related]
19. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
20. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. Reale M; Iarlori C; Gambi F; Feliciani C; Salone A; Toma L; DeLuca G; Salvatore M; Conti P; Gambi D J Neuroimmunol; 2004 Mar; 148(1-2):162-71. PubMed ID: 14975597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]